GoPath's MySmartCare360® Series includes a collection of next-generation sequencing panels that detect germline variants associated with an increased risk for various hereditary cancers. Our germline tests are clinical grade, with fast turnaround times and actionable results. We also have in-house contracted genetic counselors to aid in the interpretation of results and to provide guidance to patients.

We employ the best team, utilize the latest molecular technology and techniques, and build collaborations with key innovation partners.